Works matching IS 08991987 AND DT 2006 AND VI 45 AND IP 7

Results: 9

Gulati AP, Yang Y‐M, Harter D, Mukhopadhyay A, Aggarwal BA, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar‐Uniyal M. Mutant human tumor suppressor p53 modulates the activation of mitogen‐activated protein kinase and nuclear factor‐κB, but not c‐Jun N‐terminal kinase and activated protein‐1. Mol Carcinog 2005;45:26–37.

Published in:: Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 549, doi. 10.1002/mc.20251
Publication type:: Article

Cross reactivity between many anti‐human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma model.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 537, doi. 10.1002/mc.20200

By:

Barbara Kroczynska;
Michele Carbone

Publication type:

Article

Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 530, doi. 10.1002/mc.20188

By:

Zhang Jicai;
Yu Zongtao;
Lu Jun;
Li Haiping;
Wu Jianmin;
Hu Lihua

Publication type:

Article

Lysophosphatidic acid stimulates PC‐3 prostate cancer cell matrigel invasion through activation of RhoA and NF‐κB activityNovelty and Impact: LPA and RhoA induced prostate cancer cell invasion requires NF‐κB activity. This study supports investigations with pharmacologic NF‐κB inhibitors and anti‐inflammatory agents to control prostate cancer invasion.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 518, doi. 10.1002/mc.20183

By:

Young Sun Hwang;
Jennelle C. Hodge;
Neela Sivapurapu;
Paul F. Lindholm

Publication type:

Article

Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 543, doi. 10.1002/mc.20182

By:

Fernando Benavides;
Gregorio Gomez;
Ann Venables‐Griffith;
Isabel Lambertz;
Mónica Flores;
Joe M. Angel;
Robin Fuchs‐Young;
Ellen R. Richie;
Claudio J. Conti

Publication type:

Article

Genetic and epigenetic alterations in lung tumors from bitransgenic Ki‐rasG12C expressing mice.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 506, doi. 10.1002/mc.20181

By:

Heather S. Floyd;
Jamie E. Jennings‐Gee;
Nancy D. Kock;
Mark Steven Miller

Publication type:

Article

Expression of heregulin by mouse mammary tumor cells: Role in activation of ErbB receptorsThis article is a US Government work and, as such, is in the public domain in the United States of America.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 490, doi. 10.1002/mc.20180

By:

M. Schmitt;
M.P. Walker;
R.G. Richards;
W.P. Bocchinfuso;
T. Fukuda;
D. Medina;
F.S. Kittrell;
K.S. Korach;
R.P. DiAugustine

Publication type:

Article

Soluble nickel inhibits HIF‐prolyl‐hydroxylases creating persistent hypoxic signaling in A549 cells.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 479, doi. 10.1002/mc.20176

By:

Todd L. Davidson;
Haobin Chen;
Dominic M. Di Toro;
Gisela D'Angelo;
Max Costa

Publication type:

Article

Checkpoint kinase 1‐mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine‐induced G2/M phase cell‐cycle arrest and apoptosis.

Published in:

Molecular Carcinogenesis, 2006, v. 45, n. 7, p. 461, doi. 10.1002/mc.20165

By:

Jinn‐Shiun Chen;
Shyr‐Yi Lin;
Wei‐Ling Tso;
Geng‐Chang Yeh;
Wen‐Sen Lee;
How Tseng;
Li‐Ching Chen;
Yuan‐Soon Ho

Publication type:

Article